Modular Facility Proof-of-Concept for Multi-Modal Bioprocessing: an innovative solution

by Thomas Hauser and Jérome Dalin | November 29, 2022

Vaccines Webinar 1st December 2022

This webinar describes the collaboration of MilliporeSigma, and G-CON to develop a proof-of-concept facility design that enables multi-modal bioprocessing with greater flexibility and agility which facilitates tech transfer and future expansion. Details about the design, timelines, and cost repartition will be included.

In this presentation you will explore:

• How to develop a proof-of-concept facility design that supports multi-modal bioprocessing
• Details about the specific design, timelines, and costs
• How this modular facility approach can be leveraged for your specific requirements

Register here

Business Development Manager at G-CON

Thomas Hauser is Business Development Manager for G-CON Manufacturing within the EMEA region. He works to educate the market for offsite prefabricated and prequalified factory and clean-room solutions in a drive to bring forward the pharmaceutical facility of the future. He also supports companies in the life science segment, mainly for expansion strategies, strategic facility implementation, start-up support, and pharmaceutical packaging supply and technologies. Before 2020, Thomas worked in various leading global positions, dealing with the global life science Industry.

Senior Consultant - Bioprocessing Strategy Development at Merck KGaA, Darmstadt, Germany

Jerome Dalin holds a Msc/Engineering degree in Industrial manufacturing and Biological engineering. He started his career at Sanofi Pasteur 20 years ago in vaccine process development in France and then joined our company in 2013 to manage bioprocessing sales with vaccine project coordination at a global level. From 2021 to 2022, Jerome led strategic initiatives and supported go-to-market strategies with special focus on vaccine and traditional modalities. In his current role, he’s focusing its activities on Biopharma 4.0 strategy development.

Related Posts

Vaccines are entering a new era and recently we hosted a virtual event to share insights on market trends, challenges, and potential solutions regarding the future of vaccine manufacturing.

In this On-Demand version of the presentations, key opinion leaders from [geot_filter region="north-america"...

Can we change the Biopharma Supply Chain Game so that Everyone Gets a Trophy?

There is a popular board game based on a global disease outbreak that is generally rated 5 stars. ...

mRNA Process and Cost Modeling: A Tool to Optimize Process Development

mRNA technology has proven to enable rapid drug development. mRNA is an attractive modality to work with because...

How to model the Economics of Vaccine Manufacturing

This whitepaper describes the development and use of a cost model encompassing capital, labor, materials, consumables, and other...

Want to Increase your pDNA purity and Yields? Optimize Your pDNA Downstream Purification Process

Get a step-by-step overview of the plasmid DNA manufacturing process and the challenges in pDNA downstream purification, for...

Curious to learn more on PAT, Raman Spectroscopy, and Chemometrics?

Are you curious about Process Analytical Technologies (PAT), Raman spectroscopy, chemometrics and Raman applications in bioprocessing? Watch this...

Scroll to Top